Saliva as a source of reagent to study human susceptibility to avian influenza H7N9 virus infection
Ming Tan(Cincinnati Children's Hospital Medical Center), Xi Jiang(Cincinnati Children's Hospital Medical Center), Ke Xu(Jiangsu Provincial Center for Disease Control and Prevention), Fengjuan Shi(Jiangsu Provincial Center for Disease Control and Prevention), Lunbiao Cui(Jiangsu Provincial Center for Disease Control and Prevention), Weiwei Li(Cincinnati Children's Hospital Medical Center), Xiang Huo(Jiangsu Provincial Center for Disease Control and Prevention), Liling Chen(Taiwan Centers for Disease Control), Minghao Zhou(Jiangsu Provincial Center for Disease Control and Prevention), Weiming Zhong(Cincinnati Children's Hospital Medical Center), Pengwei Huang(Cincinnati Children's Hospital Medical Center), Xiaoyan Zeng(Jiangsu Provincial Center for Disease Control and Prevention), Ming Xia(Cincinnati Children's Hospital Medical Center)
Cited by 12
Related Papers
Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus
|New England Journal of Medicine|2013|2.3k
Co-infection with respiratory pathogens among COVID-2019 cases
|Virus Research|2020|637
Serum Cytokine and Chemokine Profile in Relation to the Severity of Coronavirus Disease 2019 in China
|The Journal of Infectious Diseases|2020|391
A Family Cluster of Infections by a Newly Recognized Bunyavirus in Eastern China, 2007: Further Evidence of Person-to-Person Transmission
|Clinical Infectious Diseases|2011|268
An integrative drug repositioning framework discovered a potential therapeutic agent targeting COVID-19
|Signal Transduction and Targeted Therapy|2021|204